Parallel Advisors, LLC Nu Cana PLC Transaction History

Parallel Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$0.74 - $3.27 $3,614 - $15,973	-4,885 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$1.95 - $2.85 $9,525 - $13,922	4,885 New	4,885 $13,000
Q2 2021 Aug 06, 2021	SELL	$2.7 - $5.04 $8,332 - $15,553	-3,086 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$4.38 - $7.0 $13,516 - $21,602	3,086 New	3,086 $15,000
Q4 2019 Jan 30, 2020	SELL	$5.55 - $8.48 $0 - $0	0 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$6.95 - $10.71 $1,202 - $1,852	-173 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$13.0 - $22.57 $3,406 - $5,913	-262 Reduced 60.23%	173 $2,000
Q4 2017 Feb 13, 2018	BUY	$10.0 - $18.72 $4,350 - $8,143	435	435 $4,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $81.9M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.